Human Microbiome Market Reveal Positive Outlook Through 2025 | Key Players : Enterome,MicroBiome Therapeutics, LLC,Rebiotix Inc.,Yakult Honsha Co.Ltd.,Osel Inc.

According to a new market research study titled "Human Microbiome Market to 2025 - Global Analysis and Forecasts by Product, Disease and Application."The global human microbiome market is expected to reach US$ 1,197.08 Mn in 2025 from US$ 257.30 Mn in 2017. The market is estimated to grow with a CAGR of 21.8% from 2018-2025. The report highlights the trends prevalent in the global human microbiome market and the factors driving the market along with those that act as deterrents to its growth.

The product segment of the human microbiome market is broadly segmented into food, medical foods, probiotics, prebiotics, drugs, diagnostic devices and supplements. In 2017, the probiotics segment held the largest share of the market, by product. However, the prebiotics is expected to grow at the fastest CAGR during the forecast period owing to growing demand for fiber rich food products is expected to drive the market. Additionally, rising investment in the food & beverage industry for innovation and development of new food products enriched with prebiotics.

For More Information Ask For Sample Report @ http://bit.ly/2SMkPln

Company Profiles

o Enterome
o MicroBiome Therapeutics, LLC
o Rebiotix Inc.
o Yakult Honsha Co., Ltd.
o Osel Inc.
o Vedanta Biosciences, Inc.
o Metabiomics Corporate
o Synthetic Biologics, Inc.
o DuPont
o BiomX Ltd.

The market for human microbiome is expected to grow as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing are expected to fuel the market growth during the forecast period. In addition, the human microbiome - a new frontier in drug discovery is likely to have a positive impact on the growth of the market in the coming years.

Increasing Incidence of Lifestyle Diseases
Over the past few decades, human microbiome is related to lifestyle diseases like cancer, diabetes, obesity, depression and many others. Changes in lifestyles and societal norms influence the microbiome at each stage of life. Altering the human microbiome can help in eliminating such lifestyle diseases.

As per World health organization in 2016, 13% of the world population (adults) were obese. According to the "The New Era of Treatment for Obesity and Metabolic Disorders: Evidence and Expectations for Gut Microbiome Transplantation" published in 2016, microbes residing in the human gastrointestinal tract act as an endocrine organ, whose composition and functionality contribute to the development of obesity. Therefore, fecal/gut microbiome transplantation (GMT), which involves the transfer of feces from a healthy donor to the patient, is a potential treatment for obesity

Purchase this Premium Report @ http://bit.ly/2uejvhs

Reasons to Buy:

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the human microbiome market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global human microbiome market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

Pune, India

About The Insight Partners :

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.